4.7 Article

Depletion of Foxp3+regulatory T cells but not the absence of CD19+IL-10+regulatory B cells hinders tumor growth in a para-orthotopic neuroblastoma mouse model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer

Alexey Revenko et al.

Summary: This study demonstrates that FOXP3 inhibitors can modulate the activity of regulatory T cells (Tregs) and enhance antitumor immunity, providing a potential therapeutic benefit in cancer models and potentially in humans.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Review Immunology

Regulatory B cells in cancer

Daniel Michaud et al.

Summary: Tumorigenesis involves genetic mutations and changes in the microenvironment, with immune cells in tumors playing a role in promoting tumor growth. Recent studies have shed light on the mechanisms of how B cells regulate immune responses, with negative regulation potentially impacting anti-tumor immune function through cytokine production.

IMMUNOLOGICAL REVIEWS (2021)

Article Oncology

Association of Genetic Polymorphisms and Serum Levels of IL-6 and IL-8 with the Prognosis in Children with Neuroblastoma

Silvia Selene Moreno-Guerrero et al.

Summary: Neuroblastoma (NB) is a heterogeneous disease with varying characteristics, and genetic variants of cytokines such as IL-6 and IL-8 may influence tumor progression and metastasis. Elevated levels of IL-6 and IL-8 could potentially serve as biomarkers for predicting poor outcomes in NB patients. The study suggests that genetic polymorphisms and serum levels of IL-6 and IL-8 play a significant role in the prognosis of NB patients, particularly in Mexican children.

CANCERS (2021)

Article Oncology

A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma

Laura Liebscher et al.

Summary: Gal-1 negatively regulates CD8+ T cells in NB, while vaccination with DNA plasmids encoding Gal-1 epitopes enhances immunity and effectively suppresses NB tumor growth.

CANCER LETTERS (2021)

Article Immunology

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

Atsushi Tanaka et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Immunology

Targeting Treg cells in cancer immunotherapy

Atsushi Tanaka et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression

Naonori Kawakubo et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

TNF-α and IFN-γ Together Up-Regulates Par-4 Expression and Induce Apoptosis in Human Neuroblastomas

Ganesh V. Shelke et al.

BIOMEDICINES (2018)

Review Medicine, Research & Experimental

Human regulatory B cells in health and disease: therapeutic potential

Claudia Mauri et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Biotechnology & Applied Microbiology

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

Andras Heczey et al.

MOLECULAR THERAPY (2017)

Review Immunology

IL-17A-Producing Foxp3+ Regulatory T Cells and Human Diseases

Min Kyung Jung et al.

IMMUNE NETWORK (2017)

Article Oncology

Circulating T-Regulatory Cells in Neuroblastoma: A Pilot Prospective Study

T. V. S. V. G. K. Tilak et al.

PEDIATRIC HEMATOLOGY AND ONCOLOGY (2014)

Article Immunology

Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy

Paula D. Bos et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Article Medicine, Research & Experimental

Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice

Mayuka Horikawa et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Medicine, Research & Experimental

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma

Madhu Gowda et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2011)

Article Immunology

Regulatory T cells and immune tolerance to tumors

Xuefang Cao

IMMUNOLOGIC RESEARCH (2010)

Article Biochemistry & Molecular Biology

Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade

Jin Zheng et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2009)

Article Oncology

Interferon-γ-Dependent Infiltration of Human T Cells into Neuroblastoma Tumors In vivo

Gregor S. D. Reid et al.

CLINICAL CANCER RESEARCH (2009)

Article Oncology

Survivin minigene DNA vaccination is effective against neuroblastoma

Stefan Fest et al.

INTERNATIONAL JOURNAL OF CANCER (2009)

Review Medicine, General & Internal

Neuroblastoma

John M. Maris et al.

LANCET (2007)

Article Oncology

CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma

Bryon D. Johnson et al.

JOURNAL OF IMMUNOTHERAPY (2007)

Article Oncology

Inhibitory effects of B cells on antitumor immunity

Satoshi Inoue et al.

CANCER RESEARCH (2006)